APA (7th ed.) Citation

Ryabukhina, Y. E., Zeynalova, P. A., Abbasbeyli, F. M., Timofeeva, O. L., Valiev, T. T., Kupryshina, N. A., & Zhukov, A. G. (2023). Isatuximab in the treatment of refractory and relapsed multiple myeloma. Онкогематология, 18(4), 90-103. https://doi.org/10.17650/1818-8346-2023-18-4-90-103

Chicago Style (17th ed.) Citation

Ryabukhina, Yu. E., P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, T. T. Valiev, N. A. Kupryshina, and A. G. Zhukov. "Isatuximab in the Treatment of Refractory and Relapsed Multiple Myeloma." Онкогематология 18, no. 4 (2023): 90-103. https://doi.org/10.17650/1818-8346-2023-18-4-90-103.

MLA (9th ed.) Citation

Ryabukhina, Yu. E., et al. "Isatuximab in the Treatment of Refractory and Relapsed Multiple Myeloma." Онкогематология, vol. 18, no. 4, 2023, pp. 90-103, https://doi.org/10.17650/1818-8346-2023-18-4-90-103.